Femke Wijk van

View Scopus Profile

Femke van Wijk

prof. dr.

 https://orcid.org/0000-0001-8343-1356
    20012025

    Research activity per year

    Personal profile

    Personal webpage

    http://www.umcutrecht.nl/en/Research/Research-programs/Infection-Immunity/Group-vanWijk

    Biography

    Dr. van Wijk obtained her PhD on mechanisms of oral tolerance and allergic sensitization to peanut at the Utrecht University in 2006. After her first postdoctoral training in human immunology in the lab of Prof. B. Prakken at the UMCU she obtained a KNAW fellowship for a 2-year postdoc in the lab of Prof. H. Cheroutre in the La Jolla Institute for Immunology in La Jolla (USA) to work on tissue T cell adaptation . After being awarded a VENI personal fellowship, she moved to the UMCU to start her own research group. For her research on how antigen presenting cells sabotage T cell regulation in local inflammation van Wijk was awarded a prestigious ZonMw VIDI career development grant (2014), and in 2021 she received a ZonMw VICI grant for her work on naïve T cell imprinting and immune development. Her research program aims to elucidate tissue T cell responses in health and inflammation and to translate these insights into tools for (pre-clinical) disease monitoring and therapeutic targeting in chronic inflammatory diseases.  She takes a disease- and age-overarching approach to decipher common and specific pathogenic processes underlying different inflammatory conditions and one of her specific interests is early imprinting of disease. Diseases her group is working on include atopic dermatitis, inflammatory bowel disease, juvenile idiopathic arthritis, juvenile dermatomyositis and immune toxicity following immune therapy in cancer.

     Dr. van Wijk is the author of >100 publications in leading peer-reviewed journals and has extensive experience with national and international scientific advisory committees (NWO off-road program, samenwerkende gezondheidsfondsen PPS Immunology consortia, Sanofi type 2 innovation grant, EU Horizon 2020 REA-FET-OPEN and COFUND). She is participating in several international networks including T_CELL_CONNECT_EUROPE, Eureka Institute for Translational Medicine, and Understanding Childhood Arthritis Worldwide Network that are aimed at (international) exchanges and training of young scientists, knowledge sharing, and enhancing reproducibility of human data. In 2017 Dr. van Wijk received the PhD supervisor of the year award by the Utrecht University Graduate School of Life Sciences.

    Dr. van Wijk is also manager research for the division paediatrics at the UMCU , and scientific director FOCIS (federation of clinical immunology societies) center of excellence.

    Fellowship & awards

    NWO Athena award for outstanding female researchers (2023)

    ZonMw VICI (2021)

    PhD Supervisor (co-promotor) of the year 2017, Graduate School of Life Sciences

    Stimulerings Associate Professorship UMCU (2015)

    ZonMw VIDI (2014)

    ZonMw Veni (2010)

    KNAW fellowship Ter Meulen Fund (2007)

     

     

    Personal webpage

    http://www.umcutrecht.nl/en/Research/Research-programs/Infection-Immunity/Group-vanWijk

    Current and former PhD students:

    http://www.eijkmanschool.org/research/index.php?id=554

    Side activities

    2016-2017 Scientific review panel member “off-road” grant program, The Netherlands Organization of Scientific Research (NWO)

    2017 Member of international advisory board new Allergy and Inflammation center Guangzhou Medical University, China (honorary)

    2019 Scientific review panel member Sanofi Genzyme European innovation grant

    2019 Scientific review panel member, Ørsted COFUND programme (co-funded by Marie Skłodowska-Curie Actions under H2020 )/ Technical University Denmark/ Denmark

    2020 Scientific review panel member  H2020 FET-Open Challenging Current Thinking, the Enhanced European Innovation Council (EIC)

    2021, 2022, 2023  Scientific review panel member The Research Foundation – Flanders (FWO)  TBM2021, Belgium

    2018-current Member Utrecht Life Sciences Program Board, domain One Health (honorary)

    2020 - current Scientific director FOCIS (federation of clinical immunology societies) center of excellence UMC Utrecht. and member FOCIS Centre of Excellence committee (honorary)

    2021-2023 Member scientific advisory committee "Samenwerkende Gezondheidsfondsen PPS Immunologie Consortia" (honorary)

    2017-current Occasional consultant/speaker for Takeda, Johnson&Johnson, Janssen, Sanofi, Regeneron, VC lspvc, Calypso biotech. 

    2023-current Member WAR ReumaNederland

     

     

     

    Education/Academic qualification

    Univeristy teaching qualification BKO, University Medical Center (UMC) Utrecht

    Award Date: 19 Apr 2017

    External positions

    Member International Scientific Advisory Board Welcome Trust Consortium Collaborative Award - On the site evaluations (2-yearly) and submitting evaluation reports - King's College London

    9 Oct 2023 → 31 Dec 2027

    lid wetenschappelijke adviesraad - advies ranking onderzoeksvoorstellen - Reuma Nederland

    1 Jan 2023 → 31 Dec 3999

    member international Scientific Advisory Board for our Wellcome Trust funded Collaborative Award - member international Scientific Advisory Board for our Wellcome Trust funded Collaborative Award - KCL London

    1 Jan 2023 → 31 Dec 3999

    Director focis center of excellence center (UMC Utrecht) - Internationaal netwerk clinical immunology societies - Federation of Clinical Immunology Societies (FOCIS)

    1 Mar 2020 → 31 Dec 3999

    Occasional consultant/speaker/advisor - gevraagd vanwege expertise - Takeda, Johnson&Johnson, Janssen, Sanofi, Regeneron, VC

    1 Jan 2017 → 31 Dec 3999

    Collaborations and top research areas from the last five years

    Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
    Explore network further
    View all 143 research outputs
    View all 60 activities
    View all 8 prizes